When a malignant tumor narrows the airway or esophagus, every breath and every swallow becomes a struggle. The Thoracent stent portfolio gives interventional pulmonologists and gastroenterologists minimally invasive tools to reopen the lumen and relieve obstructive symptoms.
Malignant central airway obstruction and dysphagia from esophageal tumors are among the most distressing complications of thoracic cancers, and stenting offers mechanical relief as part of a multidisciplinary palliative care plan. Built on established self-expanding Nitinol platforms, each stent is engineered for controlled endoscopic deployment, conformability to patient anatomy, and radial support where it’s needed most — with sizes and delivery options spanning straight tracheobronchial segments, the carina, and the esophagus, so physicians can match the device to the patient. Every device is supplied sterile, for single use.
All devices are prescription-only, for use by trained physicians. See each product’s Instructions for Use for complete indications, contraindications, warnings, and precautions.
